Back
Zoetis 10K Form
Sell
27
ZTS
Zoetis
Last Price:
175.29
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | ZTS/Zoetis Quarterly |
| 2023-11-02 | 10Q | ZTS/Zoetis Quarterly |
| 2023-08-08 | 10Q | ZTS/Zoetis Quarterly |
| 2023-05-04 | 10Q | ZTS/Zoetis Quarterly |
| 2022-11-03 | 10Q | ZTS/Zoetis Quarterly |
| 2022-08-04 | 10Q | ZTS/Zoetis Quarterly |
Receive ZTS News And Ratings
See the #1 stock for the next 7 days that we like better than ZTS
ZTS Financial Statistics
Sales & Book Value
| Annual Sales: | $8.54B |
|---|---|
| Cash Flow: | $370M |
| Price / Cash Flow: | 38.24 |
| Annual Sales: | $10.94 |
| Price / Book: | 15.98 |
Profitability
| EPS (TTM): | 5.11000 |
|---|---|
| Net Income (TTM): | $2.34B |
| Gross Margin: | $5.98B |
| Return on Equity: | 47.45% |
| Return on Assets: | 16.59% |
Zoetis Earnings Forecast
Key Zoetis Financial Ratios
- The Gross Profit Margin over the past 15 years for ZTS is 70.03%.
- The Selling, General & Administrative Expenses for ZTS have been equal to 25.18% of Gross Profit Margin.
- The Research & Development expenses have been 7.19% of Revenue.
- The Interest Expense is 10.20% of Operating Income.
- The Net Earning history of ZTS is 27.43% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 13 years.
Zoetis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ZTS |
| CUSIP: | 98978V |
| Website: | zoetis.com |
Debt
| Debt-to-Equity Ratio: | 1.32 |
|---|---|
| Current Ratio: | 3.45 |
| Quick Ratio: | 1.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.55 |
|---|---|
| Forward P/E Ratio: | 27.15 |